Neometals (ASX:NMT) share price explodes 15% on battery recycling update

A company announcement has been well received by investors. Here are the details

| More on:
A group of people in suits and hard hats celebrate the rising share price with champagne.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Neometals Ltd (ASX: NMT) share price is leading the broad indices today and is now 14.94% higher at $1.38.

Neometals shares are catching bids as investors respond positively to a company announcement regarding Primobius, a 50/50 joint venture (JV) owned by Neometals and SMS group GmbH.

Why is the Neometals share price spiking today?

The Neometals share price is soaring after the company advised its JV has executed binding option and licensing agreements with Stelco.

Neometals says Stelco is a wholly owned subsidiary of Stelco Holdings Inc (TSX: STLC), a Toronto Stock Exchange-listed steelmaking company headquartered in Ontario, Canada.

Stelco and Primobius entered into a memorandum of understanding earlier in the year to evaluate future joint lithium-ion battery recycling operations.

The parties worked together towards a significant North American lithium-ion battery recycling business plan and have now entered into binding formal arrangements.

These agreements allow Stelco to accelerate its sourcing of feedstock. Additionally, Primobius may consider equity ownership of a battery recycling special purpose vehicle (SPV) that would be responsible for battery recycling operations.

Specifically, Primobius has exclusively licensed its battery recycling technology to the SPV in the field of end-of-life vehicle battery processing. This move will enable it to "advance commercial battery feedstock sourcing agreements and advance its approvals processes".

Under a separate option agreement, Primobius can elect to acquire between 25% and 50% equity in the SPV under certain stipulations. In the event the option is not exercised, Primobius will be entitled to a gross revenue royalty.

Neometals says the SPV will "help meet the need for multiple large recycling facilities to manage significant anticipated volumes from end-of-life electric vehicle batteries originating from the world's fastest-growing cell making jurisdiction".

Stelco is now in a position to mature its feedstock targeting activities with direct access to a sustainable industrial-scale recycling solution backed by SMS, according to the release.

Management commentary

Speaking on the announcement fuelling the Neometals share price, managing director Chris Reed said:

Neometals is understandably excited by the speed of commercial progress being made by Primobius. We recognise both the need to partner to secure access to large volumes of end-of-life LIB's to ensure future growth and the present need to recycle significantly growing volumes of production scrap from LIB cell production in the US. Stelco is a leading supplier of steel to the Automotive OEMs and consumes scrap as part of its steel manufacturing process and presents the perfect opportunity for Primobius to enter the North American market as partners.

Reed concluded:

Our 10tpd commercial disposal plant in Germany addresses the needs of the LIB supply chain in Europe and builds our operating expertise as principal, further de-risking and enhancing the value of partnering with Primobius. Our impressive pipeline of development opportunities is reshaping our short-term strategy and we are prioritising market penetration over our ambitions to operate as principal. Primobius' flexible business models remain as key unique selling points.

The Neometals share price will finish the year well in the green, having climbed 420% in that time. It has also rallied more than 29% in the last month of trading.

The author has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »